Cargando…
Biologic Roles of Estrogen Receptor-β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) occurs in 10–15% of patients yet accounts for almost half of all breast cancer deaths. TNBCs lack expression of estrogen and progesterone receptors and HER-2 overexpression and cannot be treated with current targeted therapies. TNBCs often occur in African Americ...
Autores principales: | Hamilton, Nalo, Márquez-Garbán, Diana, Mah, Vei, Fernando, Gowry, Elshimali, Yahya, Garbán, Hermes, Elashoff, David, Vadgama, Jaydutt, Goodglick, Lee, Pietras, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385615/ https://www.ncbi.nlm.nih.gov/pubmed/25874233 http://dx.doi.org/10.1155/2015/925703 |
Ejemplares similares
-
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
por: Austin, David, et al.
Publicado: (2018) -
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
por: Hamilton, Nalo, et al.
Publicado: (2017) -
Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression
por: Sterling, Colin, et al.
Publicado: (2022) -
Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN
por: Wu, Yanyuan, et al.
Publicado: (2013) -
Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status
por: Mah, Vei, et al.
Publicado: (2015)